MarketWatch -- The U.S. Food and Drug Administration said Friday that Teva Pharmaceuticals USA, a subsidiary of Teva Pharmaceutical Industries Ltd., has issued a voluntary, nationwide recall of certain lots of Propofol because of the presence of elevated endotoxin levels in some vials of the injectable, general anesthesia drug. Teva has been notified that 41 patients treated with Propofol have experienced fever after operations, chills and other flu-like symptoms.
